Replies to post #89739 on Avid Bioservices Inc (CDMO)

[volgoat]

I'd expect at least $150M up front.

IF Vrtx can get $165m up front for a hepc drug in phII, we should get more, but who knows? We'll see


MOS has not been reached and we are now in September.

http://articles.marketwatch.com/2006-06-30/news/30695931_1_vertex-pharmaceuticals-pegylated-interferon-vx-950